AOD-9604 10MG

Product Overview

AOD-9604 10MG is a synthetic modified fragment related to the 177-191 region of human growth hormone, supplied as white to off-white lyophilised powder in a 10mg catalogue presentation (SKU 10AD). This page describes the stated research identity and batch-oriented catalogue specification; it does not provide an administration protocol.

AOD-9604 research derives from work on growth-hormone fragments and lipid-metabolism pathways. Published evidence includes preclinical models and limited clinical development.

Identity and Specifications

• Product: AOD-9604 10MG
• SKU: 10AD
• Format: White to off-white lyophilised powder
• Synonyms: AOD-9604, AOD9604, Tyr-hGH(177–191)
• Catalogue purity specification: ≥99%
• CAS number: 221231-10-3
• Molecular formula: C78H123N23O23S2
• Molecular weight: 1815.1 g/mol
• Amount: 10mg

Research Context

The following themes summarise published research on the named molecule or components. They are research contexts, not claims about the supplied ExtolX batch.

Areas of Research

• growth-hormone fragment structure-function
• lipid-metabolism signalling in experimental models
• receptor-independent pathway investigation
• assay design for modified peptide fragments

Evidence Quality and Limitations

The evidence base is limited and does not establish efficacy, safe administration or equivalence of this independent lyophilised research material.

Storage and Handling

Before reconstitution: Keep the lyophilised vial sealed, dry and protected from light at −20°C or below, subject to the batch-specific supplier documentation. Published AOD-9604 storage data apply to a named additive-free formulation stored desiccated below −18°C; formulation equivalence with this ExtolX batch has not been established.

After reconstitution: A published additive-free AOD-9604 formulation has a defined short refrigerated hold time, but that duration must not be transferred to an unverified formulation. Validate the solvent, concentration, pH, container, temperature and hold time for this batch. Where the validated method supports frozen storage, use single-use aliquots and avoid repeated freeze–thaw cycles. No numerical solution shelf life is stated for this listing.

Compatibility Limitations

Do not infer solubility or stability from another peptide, blend, amount or pharmaceutical formulation. Use small-scale method development and appropriate analytical controls before committing valuable material.

Laboratory Safety

Handle only in an appropriately equipped laboratory by trained personnel. Use a task-specific risk assessment, suitable personal protective equipment and applicable safety documentation. Avoid ingestion, inhalation, skin contact and environmental release, and dispose of waste in accordance with local requirements.

Sources

• ProSpec: AOD-9604 additive-free formulation storage reference
• hGH 177–191 antilipogenic study (PMID 8358331)
• Modified GH fragment study (PMID 11713213)

Scientific sources last reviewed: 23 August 2026.

Research Use Agreement & Disclaimer

For laboratory research use only. Not for human or veterinary use. Purchasers are responsible for lawful handling, storage and disposal in accordance with applicable regulations and good laboratory practice. Product information is educational and is not medical advice or evidence of efficacy.